Jinshi data news on October 7th, Notai Biology released performance forecast, it is expected that the net profit attributable to the owner of the parent company in the third quarter of 2024 will be 100 million to 140 million, an increase of 100.56% to 180.78% year-on-year. During the reporting period, the sales revenue of the company's polypeptide bulk drugs increased significantly compared to the same period last year.

Odaily Planet Daily News Block Chain Incubation Platform Seedify announced that NOTAI is its next IDO project. The total supply of NOTAI Token (BEP-20) is 100 billion, with an initial market value of approximately 88.47 million US dollars. The public round of IDO will be held from September 12th to 13th, 2024, with a Token price of $0.00009 and an allocation quota of $450,000.